Related Experiment Video
Updated: Mar 1, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
Published on: December 30, 2016
Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival
Takanobu Yoshida1, Jun Kido1, Hiroshi Mitsubuchi1
1Department of Pediatrics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Insights
Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) causes lactic acidosis. Two patients with PDHAD survived long-term with careful care, despite intellectual disability, highlighting management factors.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) is a rare metabolic disorder.
- It leads to lactic acidosis and hyperpyruvatemia, often with severe neurological impairment.
Purpose of the Study:
- To discuss factors contributing to a relatively stable clinical course in two PDHAD patients.
- To analyze the long-term survival and management of PDHAD.
Main Methods:
- Case report of two patients with PDHAD.
- Genetic analysis identifying mutations in the PDHE1α gene (p.R263Q and p.C145del).
- Clinical observation and discussion of nursing care strategies.
Main Results:
- Two patients with PDHAD, including a man with p.R263Q and a girl with p.C145del mutations, presented with lactic acidosis and neurological disorder.
- Both patients survived for extended periods under meticulous nursing care.
- Intellectual disability was a consistent feature in both cases.
Conclusions:
- Careful nursing care and management are crucial for long-term survival in PDHAD patients.
- Understanding genetic mutations and clinical presentation aids in managing PDHAD.
- PDHAD management can lead to a relatively stable clinical course despite neurological deficits.
Abstract:
Pyruvate dehydrogenase E1-alpha deficiency (PDHAD) results in lactic acidosis and hyperpyruvatemia. Two patients with PDHAD, a man with a p.R263Q mutation, and a girl with a p.C145del mutation in PDHE1α, presented with lactic acidosis with neurological disorder. These patients were able to survive for a long period under careful nursing care. Herein, we discuss the factors contributing to their relatively stable clinical course, albeit with intellectual disability.
More Related Videos
06:53Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
Published on: November 23, 2011
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Fates of Pyruvate
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Inborn Errors of Metabolism
Chronic Kidney Disease II: Clinical Manifestations
Lysosomal Hydrolases
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test